| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $242K | +4.7% | +645.4% |
| Cost of Revenue | $106K | +19.8% | +424.5% |
| R&D Expense | $12K | -53.4% | -85.2% |
| SG&A Expense | $115K | -8.5% | -17.3% |
| Interest Expense | $67K | +4.3% | +7.4% |
| Pre-tax Income | -$286K | -15.8% | +22.4% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $42K | -26.5% | -90.2% |
| Current Assets | $208K | +16.9% | -54.0% |
| Total Assets | $1.5M | +1.1% | -20.3% |
| Current Liabilities | $4.0M | +4.3% | +10.5% |
| Total Liabilities | $4.0M | +4.0% | +10.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$371K | — | — |
| Investing Cash Flow | -$18K | — | — |
| Financing Cash Flow | $238K | — | — |
| — |
| — |
| Net Income | -$286K | -15.8% | +22.4% |
| EPS (Basic) | -$0.07 | -16.7% | — |
| EPS (Diluted) | -$0.07 | -16.7% | — |
| -$2.6M |
| -5.7% |
| -42.5% |